On March 2 the Federal Aviation Administration (FAA) issued a new disease protocol for aviation medical examiners (AMEs) regarding the screening and treatment of obstructive sleep apnea (OSA) in commercial pilots. The new protocol was designed to guide AMEs in the evaluation of airmen who may be presently at risk for OSA and to outline the certification requirements for airmen diagnosed with OSA. The protocol includes risk criteria and other standards established by the AASM, and it states that sleep studies must be interpreted by a sleep medicine specialist.

Read the FAA Decision Considerations Disease Protocol for Obstructive Sleep Apnea (OSA)